JPS6218560B2 - - Google Patents

Info

Publication number
JPS6218560B2
JPS6218560B2 JP53119839A JP11983978A JPS6218560B2 JP S6218560 B2 JPS6218560 B2 JP S6218560B2 JP 53119839 A JP53119839 A JP 53119839A JP 11983978 A JP11983978 A JP 11983978A JP S6218560 B2 JPS6218560 B2 JP S6218560B2
Authority
JP
Japan
Prior art keywords
phe
trp
group
acid
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53119839A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5459293A (en
Inventor
Rinku Hansu
Kamuba Buruuno
Jiiba Peeta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS5459293A publication Critical patent/JPS5459293A/ja
Publication of JPS6218560B2 publication Critical patent/JPS6218560B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP11983978A 1977-09-28 1978-09-28 Novel cyclopeptide Granted JPS5459293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU78191A LU78191A1 (de) 1977-09-28 1977-09-28 Verfahren zur herstellung von neuen cyclopeptiden

Publications (2)

Publication Number Publication Date
JPS5459293A JPS5459293A (en) 1979-05-12
JPS6218560B2 true JPS6218560B2 (enEXAMPLES) 1987-04-23

Family

ID=19728716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11983978A Granted JPS5459293A (en) 1977-09-28 1978-09-28 Novel cyclopeptide

Country Status (18)

Country Link
US (1) US4238481A (enEXAMPLES)
EP (1) EP0001295B1 (enEXAMPLES)
JP (1) JPS5459293A (enEXAMPLES)
AT (1) AT370090B (enEXAMPLES)
AU (1) AU523050B2 (enEXAMPLES)
CA (1) CA1111841A (enEXAMPLES)
DD (1) DD140142A5 (enEXAMPLES)
DE (1) DE2861672D1 (enEXAMPLES)
DK (1) DK151034C (enEXAMPLES)
ES (1) ES473677A1 (enEXAMPLES)
FI (1) FI68246C (enEXAMPLES)
HU (1) HU184612B (enEXAMPLES)
IE (1) IE47380B1 (enEXAMPLES)
IL (1) IL55643A (enEXAMPLES)
LU (1) LU78191A1 (enEXAMPLES)
NO (1) NO148957C (enEXAMPLES)
NZ (1) NZ188517A (enEXAMPLES)
ZA (1) ZA785488B (enEXAMPLES)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
NZ195303A (en) * 1979-10-31 1984-10-19 Merck & Co Inc Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
DD155985A5 (de) * 1979-12-21 1982-07-21 Ciba Geigy Ag Verfahren zur herstellung cyclischr octapeptide
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
DE3264693D1 (en) * 1981-12-24 1985-08-14 Ciba Geigy Ag Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4798821A (en) * 1987-03-02 1989-01-17 Merck & Co., Inc. Antihypertensive therapy for diabetics
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
WO1990012811A1 (en) * 1989-04-26 1990-11-01 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
RU2177006C2 (ru) * 1995-09-29 2001-12-20 Биомежер Инкорпорэйтед Циклические пептидные аналоги соматостатина
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
EP0981363B1 (en) * 1997-05-13 2003-07-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin agonists for decreasing body weight
US7026289B2 (en) * 1997-05-13 2006-04-11 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Method and compositions for treating hyperlipidemia and other conditions
AU8019898A (en) * 1997-05-13 1998-12-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
BR0210915A (pt) 2001-06-08 2004-06-08 Sod Conseils Rech Applic Análogos quiméricos de somatostatina-dopamina
DE602004001727T2 (de) * 2003-04-07 2007-08-02 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
RU2361876C2 (ru) 2003-04-22 2009-07-20 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. Пептидные векторы
US10240138B2 (en) 2008-06-12 2019-03-26 Ipsen Bioinnovation Limited Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
CN104328100B (zh) 2008-06-12 2019-08-23 益普生生物创新有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2703499T3 (es) 2010-12-22 2019-03-11 Salk Inst Biological Studies Péptidos antagonistas de CRF cíclicos
EP3007704B1 (en) 2013-06-13 2021-01-06 Antisense Therapeutics Ltd Combination therapy for acromegaly
WO2025128794A1 (en) 2023-12-15 2025-06-19 Neurocrine Biosciences, Inc. Fatty acid conjugated cyclic peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011182A (en) * 1975-03-21 1977-03-08 American Home Products Corporation Cyclic undecapeptide analogs of somatostatin and intermediates
US4000259A (en) * 1975-06-16 1976-12-28 American Home Products Corporation Cyclic dodecapeptide analogs of somatostatin and intermediates
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
US3988304A (en) * 1975-08-25 1976-10-26 American Home Products Corporation Cyclic dodecapeptide derivatives of somatostatin and intermediates thereof
US4133805A (en) * 1975-12-16 1979-01-09 American Home Products Corporation Cyclic undecapeptides related to somatostatin and intermediates therefor
US4054558A (en) * 1976-05-24 1977-10-18 American Home Products Corporation Cyclic dodecapeptide and intermediates therefor
DE2860734D1 (en) * 1977-06-08 1981-09-03 Merck & Co Inc Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs

Also Published As

Publication number Publication date
HU184612B (en) 1984-09-28
DD140142A5 (de) 1980-02-13
EP0001295A2 (de) 1979-04-04
US4238481A (en) 1980-12-09
LU78191A1 (de) 1979-05-25
DK151034C (da) 1988-02-22
NO148957C (no) 1984-01-18
IE47380B1 (en) 1984-03-07
FI68246B (fi) 1985-04-30
FI68246C (fi) 1985-08-12
AU4022978A (en) 1980-04-03
DE2861672D1 (en) 1982-04-15
DK151034B (da) 1987-10-12
NO148957B (no) 1983-10-10
AT370090B (de) 1983-02-25
NZ188517A (en) 1981-04-24
ZA785488B (en) 1979-09-26
ES473677A1 (es) 1980-05-16
IE781931L (en) 1979-03-28
FI782907A7 (fi) 1979-03-29
CA1111841A (en) 1981-11-03
EP0001295A3 (en) 1979-06-13
IL55643A0 (en) 1978-12-17
ATA698278A (de) 1982-07-15
NO783268L (no) 1979-03-29
AU523050B2 (en) 1982-07-08
IL55643A (en) 1981-12-31
EP0001295B1 (de) 1982-03-17
JPS5459293A (en) 1979-05-12
DK428478A (da) 1979-03-29

Similar Documents

Publication Publication Date Title
JPS6218560B2 (enEXAMPLES)
KR840000927B1 (ko) 사이클로펩타이드의 제조방법
KR850000415B1 (ko) 아실펩타이드의 제조방법
US4388304A (en) Angiotensin-II analogues with antagonizing effects, containing an ester group in position 8, and a process for the preparation thereof
US4024248A (en) Peptides having LH-RH/FSH-RH activity
US4358439A (en) Cyclooctapeptides
FI94350C (fi) Menetelmä T-soluavustaja-aktiivisuutta omaavien peptidien valmistamiseksi
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
CA1140117A (en) Peptides and processes for the manufacture thereof
JPH0680079B2 (ja) ポリペプチド
EP0363589A2 (en) Somatostatin analogues
US3803309A (en) Growth hormone release stimulating pharmaceutical preparations of n-acetyl-10-17 aminoacid acth-sequence peptides
EP0101929B1 (en) Polypeptide-diesters, their production and use
JPH0631314B2 (ja) 新規なゴナドリベリン誘導体
US4118380A (en) Decapeptide analogs of somatostatin
KR0142195B1 (ko) 고나도리베린의 경쟁적 길항제
US3812091A (en) D-analogs of secretin
EP0190597A2 (en) Retro-inverso analogs of the bradykinin potentiating peptide bpp 5a
PL90224B1 (enEXAMPLES)